BerGenBio reports second quarter and half year 2022 financial results and provides business update

Corporate Breaking News

Home : BerGenBio reports second quarter and half year 2022 financial results and provides business update

Aug 23 2022	BerGenBio reports second quarter and half year 2022 financial results and provides business update
Commenced bemcentinib Phase 2b trial in hospitalized COVID-19 patients Initiation of Phase 1a/2b STK11 mutated NSCLC trial planned for 2H22 BerGenBio to host conference call and webcast today at 10:00 AM CEST/4:00 AM EDT BERGEN, Norway, Aug. 23, 2022 /PRNewswire/ -- BerGenBio ASA (OSE:...


Source:https://www.prnewswire.com:443/news-releases/bergenbio-reports-second-quarter-and-half-year-2022-financial-results-and-provides-business-update-301610460.html

Related News
» Wemade Holds the 1st Anniversary Event of MIR4 Global Service! » USD 41.04 billion Growth in Golf Tourism Market Size with 53% of the contribution from North America - 17,000+ Technavio Research Reports